Fig. 2From: Synthesis, spectroscopic, dielectric, molecular docking and DFT studies of (3E)-3-(4-methylbenzylidene)-3,4-dihydro-2H-chromen-2-one: an anticancer agent a Experimental and b predicted FT-IR spectra of MBDCBack to article page